DSM-Firmenich AG (XSWX:DSFIR) Other Stockholders Equity: CHF102 Mil (As of Dec. 2025)


XSWX:DSFIR DSM-Firmenich AG XSWX:DSFIR
32 GF Score
Price CHF74.82
GF Value CHF70.90
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Other Stockholders Equity?

DSM-Firmenich AG XSWX:DSFIR +5.62% 32 Other Stockholders Equity is CHF102 Mil as of Dec. 2025. GuruFocus rates XSWX:DSFIR with a GF Score™ of 32/100 and a GF Value™ of CHF70.90 (Fairly Valued). The stock has 5 warning signs investors should review.

DSM-Firmenich AG's Other Stockholders Equity for the quarter that ended in Dec. 2025 was CHF102 Mil.

DSM-Firmenich AG's quarterly Other Stockholders Equity declined from Dec. 2024 (CHF663 Mil) to Jun. 2025 (CHF165 Mil) and declined from Jun. 2025 (CHF165 Mil) to Dec. 2025 (CHF102 Mil).

DSM-Firmenich AG's annual Other Stockholders Equity increased from Dec. 2023 (CHF447 Mil) to Dec. 2024 (CHF663 Mil) but then declined from Dec. 2024 (CHF663 Mil) to Dec. 2025 (CHF102 Mil).

DSM-Firmenich AG Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG Other Stockholders Equity Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Other Stockholders Equity
0.00 447.02 662.86 101.71

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial 447.02 372.34 662.86 165.08 101.71
XSWX:DSFIR
32GF Score
DSM-Firmenich AG XSWX:DSFIR
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of CHF102 Mil mean?
DSM-Firmenich AG (XSWX:DSFIR) has a Other Stockholders Equity of CHF102 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's Other Stockholders Equity too high?
DSM-Firmenich AG's current Other Stockholders Equity is CHF102 Mil. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Other Stockholders Equity compare to LIN and SHW?
DSM-Firmenich AG's Other Stockholders Equity of CHF102 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current Other Stockholders Equity is CHF102 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.90, compared to a current price of CHF74.82 — trading 5.5% above its estimated fair value. The current Other Stockholders Equity is CHF102 Mil. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current Other Stockholders Equity is CHF102 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of CHF74.82 is trading 5.5% above its estimated GF Value™ of CHF70.90. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XSWX:DSFIR:

  • Other Stockholders Equity: CHF102 Mil
  • GF Value™: CHF70.90 vs. price of CHF74.82 (5.5% above fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score

Get the complete analysis for XSWX:DSFIR

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.82
Price
CHF70.90
GF Value